Physician profile
Luke Potts
NPI 1497166284
$2,110.19
in general payments reported to CMS, 2019-2025
16 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.35 · 2020: $66.25 · 2021: $469 · 2022: $350 · 2023: $337 · 2024: $391 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $400.29 | 2019-2025 | Clareon, Eysuvis, Simbrinza |
| Sun Pharmaceutical Industries INC. | $260.81 | 2021-2025 | Cequa |
| Harrow Eye, LLC | $239.52 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $229.49 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $178.26 | 2023-2025 | Miebo, Xiidra, Prolensa |
| Novartis Pharmaceuticals Corporation | $173.51 | 2021-2023 | |
| Dompe US, INC. | $126.02 | 2019-2025 | Oxervate |
| Biotissue Holdings INC. | $111.23 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $89.25 | 2020-2022 | |
| Rxsight INC | $69.71 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $66.44 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $54.15 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $42.55 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.64 | 2021 | |
| Ocular Therapeutix, INC. | $22.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $21.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.